X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18) 18
humans (15) 15
female (13) 13
male (11) 11
aged (10) 10
cancer (10) 10
middle aged (9) 9
analysis (7) 7
genetic aspects (7) 7
prognosis (7) 7
mutation (6) 6
oncology (6) 6
adult (5) 5
evolution (5) 5
genes (5) 5
genomics (5) 5
metastasis (5) 5
research (5) 5
retrospective studies (5) 5
survival (5) 5
aged, 80 and over (4) 4
biochemistry & molecular biology (4) 4
cell biology (4) 4
chemotherapy (4) 4
colorectal cancer (4) 4
colorectal neoplasms - mortality (4) 4
drug therapy (4) 4
gene expression (4) 4
genetics & heredity (4) 4
risk factors (4) 4
thrombocytosis (4) 4
tumors (4) 4
animals (3) 3
biology (3) 3
breast cancer (3) 3
breast neoplasms - genetics (3) 3
cell line, tumor (3) 3
chromosomes (3) 3
colorectal neoplasms - pathology (3) 3
colorectal neoplasms - surgery (3) 3
disease-free survival (3) 3
expression (3) 3
genetic heterogeneity (3) 3
genome (3) 3
heterogeneity (3) 3
lung neoplasms - genetics (3) 3
mutational processes (3) 3
neoplasm metastasis (3) 3
neoplasm staging (3) 3
phenotype (3) 3
phylogeny (3) 3
platelet count (3) 3
prospective studies (3) 3
thrombocytosis - etiology (3) 3
adenocarcinoma (2) 2
algorithms (2) 2
alleles (2) 2
antineoplastic agents - pharmacology (2) 2
bias (2) 2
bioinformatics (2) 2
biomarker (2) 2
biomarkers (2) 2
biomarkers, tumor (2) 2
biomarkers, tumor - genetics (2) 2
biotechnology & applied microbiology (2) 2
breast neoplasms - pathology (2) 2
cancer and oncology (2) 2
cancer och onkologi (2) 2
cancer research (2) 2
cancer therapies (2) 2
care and treatment (2) 2
chickens (2) 2
cisplatin (2) 2
cisplatin - adverse effects (2) 2
clinical medicine (2) 2
clonal evolution (2) 2
colorectal neoplasms - complications (2) 2
deoxyribonucleic acid--dna (2) 2
disease progression (2) 2
dna (2) 2
dt40 (2) 2
evolution, molecular (2) 2
follow-up studies (2) 2
gene deletion (2) 2
gene expression profiling (2) 2
gene expression regulation, neoplastic (2) 2
genetic variation (2) 2
genomes (2) 2
health aspects (2) 2
hungary (2) 2
identification (2) 2
immunology (2) 2
immunotherapy (2) 2
interleukin-6 (2) 2
intratumor heterogeneity (2) 2
ipilimumab (2) 2
kaplan-meier estimate (2) 2
klinisk medicin (2) 2
l-lactate dehydrogenase - blood (2) 2
lactate dehydrogenase (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NATURE MEDICINE, ISSN 1078-8956, 10/2019, Volume 25, Issue 10, pp. 1540 - 1540
An aim of molecular biomarkers is to stratify patients with cancer into disease subtypes predictive of outcome, improving diagnostic precision beyond clinical... 
MEDICINE, RESEARCH & EXPERIMENTAL | PROFILES | BIOCHEMISTRY & MOLECULAR BIOLOGY | INTRATUMOR HETEROGENEITY | ADENOCARCINOMAS | EARLY-STAGE | VALIDATION | PROGNOSTIC SIGNATURES | CELL BIOLOGY | SURVIVAL PREDICTION | R/BIOCONDUCTOR PACKAGE | EVOLUTION | GENE-EXPRESSION | Lung Neoplasms - genetics | Prognosis | Lung Neoplasms - mortality | Humans | Risk Factors | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Male | DNA Copy Number Variations - genetics | Transcriptome - genetics | Clonal Evolution - genetics | Genetic Heterogeneity | Whole Exome Sequencing | Disease-Free Survival | Exome - genetics | Female | Aged | Biomarkers, Tumor - genetics | RNA sequencing | Care and treatment | Usage | Lung cancer | Genetic aspects | Research | Genetic transcription | Biological markers | Hungary | RNA | Patient outcomes | Oncology, Experimental | Mortality | Genes | United Kingdom | Lung cancer, Non-small cell | Risk factors | Sweden | Analysis | Cancer | Cell proliferation | Small cell lung carcinoma | Bias | Biological evolution | Non-small cell lung carcinoma | Ribonucleic acid--RNA | Risk analysis | Gene expression | Gene sequencing | Genomic instability | Heterogeneity | Biomarkers | Diagnostic systems | Sampling | Deoxyribonucleic acid--DNA | Tumors | Clinical Medicine | Pathology | Clinical Laboratory Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Patologi | Cancer and Oncology | Klinisk medicin | Klinisk laboratoriemedicin | Cancer och onkologi
Journal Article
Genome Biology, ISSN 1474-7596, 05/2016, Volume 17, Issue 1, pp. 1 - 16
Journal Article
Cancer Immunology Immunotherapy, ISSN 0340-7004, 05/2014, Volume 63, Issue 5, pp. 449 - 458
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2019, Volume 145, Issue 3, pp. 694 - 704
A retrospective determination of the time of metastasis formation is essential for a better understanding of the evolution of oligometastatic cancer. This... 
whole genome sequencing | afatinib | tumour phylogeny | lung adenocarcinoma | cisplatin | mutagenic chemotherapy | EGFR amplification | EGFR T790M | LUNG ADENOCARCINOMAS | MUTATIONAL PROCESSES | SIGNATURES | ACQUIRED-RESISTANCE | HETEROGENEITY | Y791F | EVOLUTION | AMPLIFICATION | GENE | ONCOLOGY | ASSOCIATION | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Genome-Wide Association Study | ErbB Receptors - antagonists & inhibitors | Adenocarcinoma of Lung - pathology | Humans | ErbB Receptors - genetics | Lung Neoplasms - pathology | Mutagenesis - drug effects | Adenocarcinoma of Lung - blood | Cisplatin - administration & dosage | Genomic Imprinting - drug effects | Gefitinib - adverse effects | Protein Kinase Inhibitors - administration & dosage | Neoplasm Metastasis | Adenocarcinoma of Lung - genetics | Algorithms | Gene Rearrangement | Adenocarcinoma of Lung - drug therapy | Cisplatin - adverse effects | Gefitinib - administration & dosage | Lung Neoplasms - blood | Models, Genetic | Retrospective Studies | Chemotherapy | Genomics | Methamphetamine | Evolution | Genetic aspects | Metastasis | Phylogeny | Tumor proteins | Health aspects | Cancer | Adenocarcinoma | Autopsies | Epidermal growth factor receptors | Nucleotide sequence | Genomes | Cancer therapies | Patients | Cisplatin | Metastases | Gene frequency | Tempering | Lungs | Autopsy | Mutation | Temporal variations | Gefitinib | Tumors | Index Medicus
Journal Article
F1000Research, ISSN 2046-1402, 2014, Volume 3, p. 180
Thrombocytosis portends adverse prognostic significance in many types of cancers including ovarian and lung carcinoma. In this study, we determined the... 
Bleeding & Coagulation Disorders | Supportive & Palliative Cancer Care
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2019, Volume 145, Issue 3, pp. 694 - 704
Journal Article
Cell, ISSN 0092-8674, 04/2018, Volume 173, Issue 3, pp. 595 - 610.e11
Journal Article
Biomarker Research, ISSN 2050-7771, 2016, Volume 4, Issue 1, p. 4
Stage I lung adenocarcinoma is usually not treated with adjuvant chemotherapy; however, around half of these patients do not survive 5 years. Therefore, a... 
Early stage cancer | Lung adenocarcinoma | Gene expression | Prognostic biomarker | Adenocarcinoma | Lung cancer | Analysis | Adjuvant treatment | Genetic aspects | Drug therapy | Health aspects | Cancer
Journal Article
Oncogene, ISSN 0950-9232, 02/2017, Volume 36, Issue 6, pp. 746 - 755
Journal Article
Pathology & Oncology Research, ISSN 1219-4956, 9/2015, Volume 21, Issue 4, pp. 991 - 997
Journal Article